Description
Cabotres is an anti-cancer prescription medication (manufactured by Cipla Ltd) containing the active ingredient Cabozantinib. Classified as a tyrosine kinase inhibitor, it works by blocking specific proteins in the body, which stops the growth, spread, and creation of new blood vessels that feed abnormal cancer cells. [1, 2, 3, 4]
Primary Uses
Cabotres is primarily used to treat adults with: [1]
- Advanced kidney cancer (renal cell carcinoma).
- Locally advanced or metastatic thyroid cancer.
- Liver cancer (hepatocellular carcinoma) in patients who have previously been treated with sorafenib
Reviews
There are no reviews yet.